Subsequently, in an observational study involving only 518 participants, Hu et al. demonstrated that lower levels of osteocalcin and 25-hydroxy vitamin D were closely associated with a greater prevalence of hypertension, suggesting that abnormalities in bone metabolism may play a role in the development and progression of hypertension [18]. This evidence concerns the gene BGLAP and Hypertension.